A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study

Código QR

A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study

Thomas Kaercher,1 Ulrich Thelen,2 Gerrett Brief,3 Robert J Morgan-Warren,4 Richard Leaback41Augenarztpraxis, Heidelberg, Germany; 2University of Münster, Münster, Germany; 3Ruhr University, Bochum, Germany; 4Allergan Holdings Ltd, Marlow, UK  Objective: The aim was to ev...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kaercher T, Thelen U, Brief G, Morgan-Warren RJ, Leaback R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/c82b211bd92d420689b757fe9f551453
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Treatment of patients with keratoconjunctivitis sicca with Optive&trade;: results of a multicenter, open-label observational study in Germany
por: Thomas Kaercher, et al.
Publicado: (2008)

Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
por: Alanazi SA, et al.
Publicado: (2019)

Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
por: Fogagnolo P, et al.
Publicado: (2020)

A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome
por: Diaz-Llopis M, et al.
Publicado: (2019)

TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease
por: Badawi D
Publicado: (2019)

A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease
por: Badawi D
Publicado: (2018)

Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial
por: Simmons PA, et al.
Publicado: (2015)

A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
por: Karpecki P, et al.
Publicado: (2020)

Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
por: Kaya A, et al.
Publicado: (2016)

Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study
por: Tellez-Vazquez J
Publicado: (2016)

Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
por: Miyake K, et al.
Publicado: (2017)

A randomized clinical evaluation of the safety of Systane&reg; Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery
por: Daniel Durrie, et al.
Publicado: (2008)

Effects of Systane® Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye
por: Aguilar AJ, et al.
Publicado: (2014)

Use of preservative-free hyaluronic acid (Hylabak®) for a range of patients with dry eye syndrome: experience in Russia
por: Brzhesky VV, et al.
Publicado: (2014)

ROM Plus®: accurate point-of-care detection of ruptured fetal membranes
por: McQuivey RW, et al.
Publicado: (2016)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018)

The association of sleep quality with dry eye disease: the Osaka study
por: Kawashima M, et al.
Publicado: (2016)

Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra®) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease
por: Hovanesian JA, et al.
Publicado: (2021)

Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study
por: Aragona P, et al.
Publicado: (2020)

Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose
por: Wallerstein A, et al.
Publicado: (2018)

Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK
por: Astakhov YS, et al.
Publicado: (2013)

Ocular Application of Oleuropein in Dry Eye Treatment: Formulation Studies and Biological Evaluation
por: Susi Burgalassi, et al.
Publicado: (2021)

The challenge of dry eye diagnosis
por: Giacomo Savini, et al.
Publicado: (2008)

Systane&reg; lubricant eye drops in the management of ocular dryness
por: Benelli U
Publicado: (2011)

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial
por: Yeu E, et al.
Publicado: (2020)

The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye.
por: Adam Master, et al.
Publicado: (2021)

The use of preservatives in dry eye drops
por: Walsh K, et al.
Publicado: (2019)

Comparison of Autonomous AS-OCT Deep Learning Algorithm and Clinical Dry Eye Tests in Diagnosis of Dry Eye Disease
por: Chase C, et al.
Publicado: (2021)

Effectiveness of NEM® brand eggshell membrane in the treatment of suboptimal joint function in dogs: a multicenter, randomized, double-blind, placebo-controlled study
por: Ruff KJ, et al.
Publicado: (2016)

Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial
por: Simmons PA, et al.
Publicado: (2015)

Neutrophil/Lymphocyte Ratio as an Inflammatory Predictor of Dry Eye Disease: A Case-Control Study
por: Meng YF, et al.
Publicado: (2021)

Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome
por: Yi-Zhou Chen, et al.
Publicado: (2021)

PERSIST: Physician&#39;s Evaluation of Restasis&reg; Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
por: Mah F, et al.
Publicado: (2012)

Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial
por: Pierre Thomas, et al.
Publicado: (2008)

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
por: Silverstein S, et al.
Publicado: (2020)

Trends in Dry Eye Disease Management Worldwide
por: Hantera MM
Publicado: (2021)

Advances in the Noninvasive Diagnosis of Dry Eye Disease
por: Luca Di Cello, et al.
Publicado: (2021)

Tear osmolarity and dry eye symptoms in diabetics
por: Fuerst N, et al.
Publicado: (2014)

Corneal thickness in dry eyes in an Iraqi population
por: Ali NM, et al.
Publicado: (2017)

Diagnosis of dry eye disease and emerging technologies
por: Zeev MSB, et al.
Publicado: (2014)